期刊文献+

间充质干细胞和支架材料在盆腔脏器脱垂治疗中的应用现状和研究进展 被引量:2

原文传递
导出
摘要 盆腔脏器脱垂是一种发病率高、且严重影响女性生活质量的非致死性疾病。经阴道植入聚丙烯网片是临床常用的治疗方法,但其不良反应限制了广泛应用,目前寻找有更好组织相容性的移植物迫在眉睫。干细胞治疗可改善组织相容性,极大程度地减少不良炎症反应,是盆腔脏器脱垂极有前景的治疗手段。本文总结了间充质干细胞与网片相互作用的相关研究,根据现有的研究结果评估干细胞的治疗潜能。干细胞治疗有望成为增强盆底组织的有效工具。
出处 《中华医学杂志》 CAS CSCD 北大核心 2020年第31期2477-2480,共4页 National Medical Journal of China
基金 国家自然科学基金(81830043) 北京市自然科学基金(7192154) 中央高校基本科研业务费资助项目(3332019131)。
  • 相关文献

参考文献4

二级参考文献37

  • 1Schneeberger S,Landin L,Jableki J, et al. Achievements andchallenges in composite tissue allotransplantation[ J]. Transpl Int,2011,24(8) ; 760-769. DOI: 10. 1111/j. 1432-2277. 2011.01261.x.
  • 2Cheng HY, Nicolae G, Huang WC, et al. Syngeneic adipose-derived stem cells with short-term immunosuppression inducevascularized composite allotransplantation tolerance in rats [ J ].Cytotherapy, 2014, 16(3) : 369-380. DOI: 10. 1016/j. jcyt.2013.06.020.
  • 3Morelon E,Kanitakis J, Petruzzo P, et al. ImmunologicalChallenges in Vascularised Composite Allotransplantation [ J ].Curr Transplant Rep, 2015,2(3) : 276-283. DOI: 10. 1007/.
  • 4Melief SM, Zwaginga JJ, Fibbe WE, et al. Adipose tissue-derived multipotent stromal cells have a higher immunomodulatorycapacity than their bone marrow-derived counterparts [ J ]. StemCells Transl Med, 2013,2(6) : 455463. DOI: 10. 5966/sctm.2012-0184.
  • 5Davis TA, Anam K, Lazdun Y, et al. Adipose-Derived StromalCells Promote Allograft Tolerance Induction [ J ]. Stem Cells TranslMed, 2014, 3(12): 1444-1450. DOI: 10. 5966/sctm. 2014-0131.
  • 6Del Bene M, Di Caprio AP, Melzi ML, et al. AutologousMesenchymal Stem Cells as a New Strategy in ImmunosuppressantTherapy in Double Hand Allotransplantation [ J]. Plast ReconstrSurg, 2013,131 ( 2 ): 305e-307e. DOI: 10. 1097/PRS.0b013e318278d648.
  • 7Fryer M,Grahammer J, Khalifian S, et al. Exploring cell-basedtolerance strategies for hand and face transplantation. ExpertReview of Clinical Immunology [ J ]. Expert Rev Clin Immunol,2015,11 (11): 1189-1204. DOI: 10. 1586/1744666x. 2015.1078729.
  • 8Plock JA, Schnider JT, Zhang W, et al. Adipose- and BoneMarrow-Derived Mesenchymal Stem Cells Prolong Graft Survival inVascularized Composite Allotransplantation[ J]. Transplantation,2015, 99 ( 9 ): 1765-1773. DOI: 10. 1097/tp.0000000000000731.
  • 9Dominici M, Le Blanc K, Mueller I,et al. Minimal criteria fordefining multipotent mesenchymal stromal cells [ J ]. TheInternational Society for Cellular Therapy position statement.Cytotherapy, 2006,8(4): 315-317. DOI: 10. 1080/14653240600855905.
  • 10Kueckelhaus M, Fischer S, Seyda M, et al. Vascularizedcomposite allotransplantation : current standards and novelapproaches to prevent acute rejection and chronic allograftdeterioration [ J ]. Transpl Int, 2015. DOI: 10. 1111/tri. 12652.[Epub ahead of print]. http://www. ncbi. nlm. nih. gov/pubmed/?term = Vascularized + composite + allotransplantation% 3A +current + standards + and + novel + approaches + to + prevent +acute + rejection + and + chronic + allograft + deterioration.

共引文献16

同被引文献12

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部